Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 12.11.2019 Börsentäglich über 12.000 News von 617 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1T980 ISIN: US36197T1034 Ticker-Symbol: GW2A 
Tradegate
12.11.19
11:01 Uhr
103,00 Euro
0,00
0,00 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
GW PHARMACEUTICALS PLC ADR Chart 1 Jahr
5-Tage-Chart
GW PHARMACEUTICALS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
102,00
104,00
11:32
102,00
104,00
11:01

Aktuelle News zur GW PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
Börsennews zur GW PHARMACEUTICALS Aktie und weiteren Hot Stocks erhalten
MoGW Pharma shares rise after UK recommends NHS reimburse its CBD-based epilepsy drug3
MoGW Pharma scores the industry's first NICE nods for cannabis-based medicines2
MoEngland's NHS watchdog on board with GW Pharma's Epidyolex & Sativex4
MoNICE backs first cannabis-based drugs, both from GW Pharma-
MoGW Pharma Receives Positive NICE Recommendation For EPIDYOLEX Oral Solution6
MoGW Pharmaceuticals plc: GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy1.144GW also welcomes the positive guideline recommendation for Sativex (nabiximols) for the treatment of spasticity due to multiple sclerosis as part of NICE's evaluation of cannabis-based medicinal products...
► Artikel lesen
DoBetter Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals25
MiAnalysts Remain Upbeat On GW Pharma's Optionality With Epidiolex19
MiHere's Why GW Pharmaceuticals Is Falling Today44
MiThe Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings26
MiGW Pharmaceuticals Trounces Q3 Estimates -- and Investors Still Weren't Happy47
MiGW PHARMACEUTICALS PLC - 10-Q, Quaterly Report12
MiGW Pharmaceuticals plc (GWPH) CEO Justin Gover on Q3 2019 Results - Earnings Call Transcript25
05.11.GW Pharmaceuticals Reports Q3 Sales Beat, Stock Falls23
05.11.Marijuana-derived epilepsy-drug sales rise 25%, but GW Pharma stock plunges more than 12%22
05.11.GW PHARMACEUTICALS PLC - 8-K, Current Report6
05.11.GW Pharmaceuticals Q4 Earnings Outlook10
01.11.Nabis Holdings schließt Übernahme von Emerald Phoenix und Infusion Edibles in Arizona ab - diese Cannabisaktie liefert ab!
31.10.GW Pharmaceuticals plc: GW Pharmaceuticals to Present at Upcoming Investor Conferences5
30.10.What's in Store for GW Pharmaceuticals (GWPH) in Q3 Earnings?6
Seite:  Weiter >>
119 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
4,3,2